TRUSTED BY CLINICAL RESEARCH LEADERS
A Better Trial Experience for Sites, Participants,
and Study Teams. And Better Results.
business days from submission to review
New protocol and initial
informed consent for multisite
studies (full board review)
business days from submission to review
New protocols and initial
informed consent
(minimal risk review)
business days from submission to review
New site for a multisite
study
Please note: Turnaround time is dependent upon complete and accurate submission of study documents.
Any follow up requiring a response may extend this turnaround time.
Expert IRB Reviews for Every Phase, Modality, and
Therapeutic Area
Our experience helps accelerate your review
Need the Current IRB Roster?
Login to the Advarra CIRBI Platform and select the “Reference Materials” tab
Request the latest IRB roster
Get Answers to Common Questions About Our Independent IRB
Are You a Research Participant?
Find out how the IRB helps protect
your rights and welfare.